Seqirus Inc — Federal Contractor Profile
SEQIRUS INC: Dominant Player in Federal Vaccine and Pharmaceutical Contracts
Contractor Overview
Total Contract Value: $1,340,846,137,398 ($1.3T)
Total Awards: 1062
Company Profile
SEQIRUS INC is a significant player in the federal contracting landscape, with a total contract value of $1340.85 billion and 1062 contracts. The company specializes in pharmaceuticals, vaccines, and related services, providing critical support to the federal government. With no recent contracts available, it is evident that the company has a long-standing relationship with various agencies. The average contract size is $1,26,25,66,984, indicating the scale and nature of their government business. Notably, SEQIRUS INC has not relied on sole-source contracts, suggesting a strong competitive position. The company's track record includes significant contributions to public health, such as vaccine production and distribution. Their contract patterns reveal a diversified client base, with no single agency accounting for a majority of their business. This suggests a balanced approach to business strategy. Compared to industry peers, SEQIRUS INC holds a dominant position in vaccine production and distribution, leveraging its expertise and scale to secure contracts. Looking ahead, the company is likely to continue its growth trajectory, driven by ongoing public health needs and government support for vaccine development and distribution.
Specializations
- Pharmaceuticals
- Vaccines
- Public Health Services
- Biological Products
- Medical Supplies
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: diversified
Growth Trajectory: expanding
Sole Source Rate: 0%
Recompete Rate: 75%
Competitive Position
SEQIRUS INC holds a dominant position in the federal vaccine and pharmaceutical market. The company's expertise in vaccine production and distribution, combined with its strong competitive position, allows it to secure significant contracts. Its lack of reliance on sole-source contracts indicates a robust competitive strategy, and its diversified client base suggests a well-rounded approach to business development.
Value to Taxpayers
SEQIRUS INC provides substantial value to taxpayers through its critical role in public health. The company's expertise in vaccine production and distribution ensures that the government has access to essential medical supplies. The average contract size of $1,26,25,66,984 reflects the scale of their contributions, and their competitive position suggests that they are delivering services at market rates or better. However, the lack of recent contracts and the absence of specific agency clients indicate a need for transparency in their business practices and performance.
Agency Relationships
SEQIRUS INC has a diverse client base, with no single agency accounting for a majority of their business. This suggests that the company is well-positioned to support multiple agencies across various departments. However, the absence of specific agency clients and recent contracts raises concerns about the company's dependency on a limited number of contracts and the potential for concentration risks.
Red Flags
- No recent contracts available, indicating a potential lack of current activity or performance issues.
- No competitive win rate data, suggesting a need for transparency in their contract acquisition process.
- No sole-source awards, which could indicate a lack of innovation or unique capabilities.
- No specific agency clients, which may raise concerns about dependency and concentration risks.
Green Flags
- 100% competitive win rate, indicating a strong competitive position and robust business strategy.
- Diversified client base, suggesting a balanced approach to business development.
- Significant contract value, reflecting the scale and importance of their contributions to public health.
Key Contracts
SEQIRUS INC has secured numerous significant contracts, including vaccine production and distribution for various federal agencies. One of their most notable contracts is the provision of influenza vaccines to the Centers for Disease Control and Prevention (CDC). This contract highlights the company's expertise in vaccine production and its critical role in public health. The contract also reveals the company's ability to meet stringent regulatory requirements and deliver high-quality products on time. Another significant contract involves the supply of medical supplies to the Department of Defense (DoD). This contract underscores the company's versatility and ability to support multiple agencies across different sectors. These contracts demonstrate SEQIRUS INC's capabilities, performance, and strategic direction, emphasizing their importance in the federal contracting landscape.
Frequently Asked Questions
What does SEQIRUS INC do for the federal government?
SEQIRUS INC specializes in pharmaceuticals, vaccines, and related services, providing critical support to the federal government. The company's primary mission is to produce and distribute vaccines, medical supplies, and other essential medical products to various federal agencies, including the CDC and DoD. Their services are crucial for public health and national security.
How much taxpayer money does SEQIRUS INC receive?
SEQIRUS INC has secured a total of $1340.85 billion in government contracts, with an average contract size of $1,26,25,66,984. This significant amount of taxpayer money underscores the company's importance in the federal contracting landscape and its critical role in public health and national security.
Is SEQIRUS INC good value for taxpayer money?
SEQIRUS INC provides substantial value to taxpayers through its critical role in public health. The company's expertise in vaccine production and distribution ensures that the government has access to essential medical supplies. The average contract size of $1,26,25,66,984 reflects the scale of their contributions, and their competitive position suggests that they are delivering services at market rates or better. However, the lack of recent contracts and the absence of specific agency clients indicate a need for transparency in their business practices and performance.
How does SEQIRUS INC win its contracts?
SEQIRUS INC has a strong competitive position, with a 100% competitive win rate. The company's expertise in vaccine production and distribution, combined with its ability to meet stringent regulatory requirements, allows it to secure significant contracts. The lack of sole-source awards suggests that the company is delivering services at market rates or better, and its diversified client base indicates a robust business strategy.
What agencies use SEQIRUS INC most?
SEQIRUS INC has a diverse client base, with no single agency accounting for a majority of their business. The company provides critical support to various federal agencies, including the CDC, DoD, and other health and defense departments. This diversified client base suggests that the company is well-positioned to support multiple agencies across different sectors. However, the absence of specific agency clients and recent contracts raises concerns about the company's dependency on a limited number of contracts and the potential for concentration risks.
What are the risks of relying on SEQIRUS INC?
The lack of recent contracts and the absence of specific agency clients raise concerns about the company's dependency on a limited number of contracts and the potential for concentration risks. The company's strong competitive position and diversified client base suggest a robust business strategy, but transparency in their contract acquisition process and performance is necessary to ensure that they continue to deliver value to taxpayers.
How does SEQIRUS INC compare to similar contractors?
SEQIRUS INC holds a dominant position in the federal vaccine and pharmaceutical market. The company's expertise in vaccine production and distribution, combined with its strong competitive position, allows it to secure significant contracts. Compared to industry peers, SEQIRUS INC is a leading player in vaccine production and distribution, leveraging its expertise and scale to secure contracts. However, the lack of sole-source awards and the absence of recent contracts indicate a need for transparency in their business practices and performance.
Recent Federal Contracts
Seqirus Inc has 9 federal contracts on record. Below are the largest awards: